ARFH Reps attend Paris meeting – TB (Abuja, October 28th 2013)
Representatives from ARFH to attend Paris meeting on Tuberculosis
A team from Association for Reproductive and Family Health (ARFH) will be in v Paris to attend the 44th Union World Conference on Lung Health in Paris. The conference organised each year by the International Union Against Tuberculosis and Lung Disease (The Union) will be held on 30 October – 3 November 2013 at the Palais des Congrès In Paris, France. The event is the largest annual meeting experts to discuss the latest research and programme developments in tuberculosis and lung disease, as well as related problems, such as HIV, non-communicable diseases and tobacco control.
As a Global Fund Principal Recipient in Nigeria, ARFH is one of the leading indigenous non-governmental and non-profit organizations in Nigeria committed to improving the quality of life of under-served and vulnerable communities by promoting access to quality health care and harnessing community capacities for sustainable development. The team attending the conference includes the Mrs Kehinde Osinowo, Director of Programs; Dr Queen Ogubuji, TB Project Coordinator; Dr Adewale Osho, Manager http://buyclomidovulation.com/ anchoring National TB & Leprosy Control Programme; Dr Abiodun Hassan, Monitoring and Evaluation Coordinator and other officers associated with tuberculosis management programme.
We are looking forward to the event as a platform to share best practices, learn information on innovative measures to control TB in Nigeria and engage in conversation that will move the TB Conrol programme in Nigeria foward. We will be giving three presentations on barriers to TB treatment, Perception of Community members from the Knowledge, Attitude and Practice Survey in Nigeria; Social determinants of the TB epidemics in Nigeria – A quality Study and Community Perspective on causes, transmission, prevention and it effects on health seeking behaviour to TB in Nigeria said Dr. Queen Ogbuji.
WHO, in its latest report on tuberculosis (TB), has stated that Nigeria needs to speed up its capacity for diagnosis and treatment of patients, especially those suffering from multi-drug resistant. The report futher stated that an estimated 1.1 Million (38%) of the 8.6 million people who developed TB in 2012 were HIV-Positive. About 75% lives in the Africa Region.
For enquiry contact Esther on +2348161619902 or email firstname.lastname@example.org